In the randomised study, published in the journal Inflammopharmacology, 38 knee osteoarthritis sufferers took 3,000mg daily of either GlycOmega Plus green-lipped mussel extract or glucosamine sulphate over 12 weeks.
Participants taking GlycOmega Plus reported reduced use of analgesic medication during the 12-week period. Those taking glucosamine did not reduce their intake of painkillers as much during the study.
Although the University of Queensland study involved Aroma NZ’s GlycOmega Plus, it was not sponsored by the New Zealand-based company.
Director Ben Winters Jr said: “The excellent results from this latest independent trial show that our green-lipped mussel powder worked more rapidly and provided faster relief than glucosamine for the arthritis sufferers who took part.
“The study proved that Aroma NZ’s GlycOmega Plus significantly helped reduce joint pain and increased joint mobility in patients and confirmed that our green-lipped mussel ingredient definitely contains significant anti-inflammatory properties.”
Source: Aroma NZ
.
© FoodBev Media Ltd 2024